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Zn2+ is thought to modulate neurotransmission by
affecting currents mediated by ligand-gated ion chan-
nels and transmitter reuptake by Na+-dependent trans-
porter systems. Here, we examined the in vivo rele-
vance of Zn2+ neuromodulation by producing knockin
mice carrying the mutation D80A in the glycine recep-
tor (GlyR) a1 subunit gene (Glra1). This substitution
selectively eliminates the potentiating effect of Zn2+
on GlyR currents. Mice homozygous for Glra1(D80A)
develop a severe neuromotor phenotype postnatally
that resembles forms of human hyperekplexia (startle
disease) caused by mutations in GlyR genes. In spinal
neurons and brainstem slices from Glra1(D80A) mice,
GlyR expression, synaptic localization, and basal gly-
cinergic transmissionwere normal; however, potentia-
tion of spontaneous glycinergic currents by Zn2+ was
significantly impaired. Thus, the hyperekplexia pheno-
type of Glra1(D80A) mice is due to the loss of Zn2+
potentiationofa1subunit containingGlyRs, indicating
that synaptic Zn2+ is essential for proper in vivo
functioning of glycinergic neurotransmission.
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The mammalian central nervous system (CNS) contains
high concentrations of the divalent metal ion Zn2+. Al-
though acute Zn2+ deficiency impairs brain development
and function in experimental animals and humans (over-
view in Choi and Koh [1998]), the roles of Zn2+ in the CNS
remain enigmatic. Ninety percent of the total Zn2+ in
brain tissue is tightly bound to proteins, and only 10%
exists in a pool of chelatable ‘‘free’’ Zn2+. This chelatable
Zn2+ is not evenly distributed in the brain but highly
enriched in distinct glutamatergic nerve terve terminals
(Choi and Koh, 1998). Furthermore, enrichment of Zn2+
at selected inhibitory synapses in cerebellum and spinal
cord has also been reported (Vela´zquez et al., 1999; Jo
et al., 2000; Danscher et al., 2001; Wang et al., 2001,
2002; Danscher and Stoltenberg, 2005). Estimates of
free Zn2+ concentrations in the CNS vary between 100
and 200 nM in the cerebrospinal fluid and >200 mM within
specific synaptic regions (Choi and Koh, 1998). Elevated
concentrations of Zn2+ (>100 mM) may contribute to neu-
ronal cell death during brain ischemia, seizures, trauma,
and neurodegeneration (Choi and Koh, 1998; Doraisw-
amy and Finefrock, 2004), whereas lower levels of Zn2+
(<10 mM) protect neurons against glutamate-induced
cell death (Chen and Liao, 2003; Chandra et al., 2005).
Hence, proper regulation of Zn2+ homeostasis is thought
to be crucial for brain function and development.
At synapses, Zn2+ is highly enriched in synaptic vesi-
cles, from which it can be coreleased with glutamate in
an activity-dependent manner (Assaf and Chung,
1984). Microfluorescence imaging of Zn2+ secretion dur-
ing presynaptic stimulation has provided evidence for a
quantal mode of Zn2+ release from hippocampal Mossy
fiber terminals (Li et al., 2001; Qian and Noebels, 2005);
however, the interpretation of the signals obtained in
these studies has been a matter of debate (see Kay
[2006]). The loading of synaptic vesicles with releasable
Zn2+ is thought to be mediated by ZnT3, a member of the
SLC30 superfamily of Zn2+ transporters (Cole et al.,
1999). In addition, synaptic Zn2+ concentrations are con-
trolled by other Zn2+ transporters of the ZnT (SLC30) and
Zip (SLC39) families as well as by Zn2+-sequestering
proteins, like metallothioneins (Baranano et al., 2001;
Kambe et al., 2004; Smart et al., 2004). Since Zn2+ mod-
ulates both current responses mediated by excitatory
and inhibitory neurotransmitter receptors and the effi-
cacy of transporter driven neurotransmitter reuptake
(Smart et al., 2004), synaptically released Zn2+ has
been proposed to function as an important regulator of
synaptic transmission and plasticity (Lu et al., 2000;
Vogt et al., 2000) and/or ‘‘atypical neurotransmitter’’
(Baranano et al., 2001). This concept has, however,
been challenged because (1) mice deficient in ZnT3
were found to be behaviorally normal despite a loss of
synaptic Zn2+ staining (Cole et al., 1999) and (2) the avail-
able Zn2+ imaging techniques have been argued to be
particularly sensitive to artifacts (Kay, 2006).
In this study, we have chosen a genetic approach
to unravel the importance of Zn2+ for synaptic
Neuron
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Zn2+ affects the function of the strychnine-sensitive gly-
cine receptor (GlyR; Bloomenthal et al., 1994; Laube
et al., 1995), which mediates postsynaptic inhibition in
motor and sensory pathways (overview in Betz and
Laube [2006]). In spinal neurons and cells expressing
recombinant GlyRs, low micromolar (<10mM) concentra-
tions of Zn2+ enhance glycinergic currents, whereas
higher concentrations (>10 mM) have an inhibitory effect.
The effects of low concentrations of Zn2+ have been at-
tributed to an increase in agonist affinity resulting from
decreased agonist dissociation; higher Zn2+ concentra-
tions produce a voltage-independent block by reducing
the efficacy of channel opening (Laube et al., 2000;
Lynch, 2004). Also, GlyR-mediated miniature inhibitory
postsynaptic currents (mIPSCs) have been shown to
be modulated by Zn2+ (Suwa et al., 2001; Laube, 2002),
indicating that Zn2+ regulation is effective at synaptic
sites. Mutational studies have localized the Zn2+ binding
sites mediating potentiation and inhibition of GlyRs in
distinct regions of the N-terminal extracellular domain
of GlyR a subunits (Laube et al., 2002; Lynch, 2004). Spe-
cifically, residues D80, E192, D194, and H107, H109,
T112 of the adult-type GlyR a1 subunit have been found
to constitute important determinants of Zn2+ potentia-
tion and inhibition, respectively (Lynch et al., 1998;
Harvey et al., 1999; Laube et al., 2000; Miller et al.,
2005). Neutralization of the g-carboxylate of aspartate
80 by glycine or alanine substitution selectively elimi-
nates Zn2+ potentiation without affecting channel con-
ductance and receptor kinetics (Lynch et al., 1998; Laube
et al., 2000). Here, we introduced the D80A substitution
into the murine GlyR a1 gene locus (Glra1) via homolo-
gous recombination. Knockin mice homozygous for
Glra1(D80A) show a phenotype, which mimicks that of
human hyperekplexia (hereditary startle disease) pa-
tients and spasmodic or spastic GlyR mutant mice and
is indicative of decreased glycinergic inhibition (Scho-
field, 2002). Our results indicate that potentiation of the
GlyR by synaptic Zn2+ is essential for proper glycinergic
inhibition in vivo.
Results
Generation of Glra1(D80A) Mice and GlyR Protein
Expression
The targeting strategy used for introducing the D80A
substitution into exon 4 ofGlra1 is depicted in Figure 1A.
Using a replacement type targeting vector, the mutation
was introduced into ES cells by homologous recombina-
tion together with a diagnostic XbaI restriction site and
a floxed neomycin resistance cassette (neo), positioned
in the 30 adjacent intron. Homologous recombination
events were identified by PCR, and confirmed by South-
ern blot analysis (Figures 1A and 1B). In a second step,
the neo selection marker was deleted by transient trans-
fection with a Cre recombinase expression vector (Fig-
ure 1C). The resulting mutant ES cells were injected
into blastocysts and gave rise to two germline-transmit-
ting chimeras. These animals sired heterozygous off-
spring without obvious abnormalities in morphology
and behavior. Intercrosses of heterozygous animals
generated Glra1(D80A) homozygous, heterozygous,
and WT animals at the expected Mendelian ratios.Correct introduction of the mutation Glra1(D80A) was
confirmed by Southern blotting (Figure 1D) of XbaI-
digested DNA and corroborated by sequencing the
exon 4 region of the mutant locus (data not shown).
To examine whether GlyR a1 subunit expression is un-
altered in homozygous Glra1(D80A) mice, we analyzed
GlyR expression in spinal cord tissue from postnatal
day 21 (P21) mice. Immunoblot analysis of spinal mem-
brane preparations with an antibody which recognizes
all GlyR a subunits (mAb4a) or an antibody specific for
the a1 subunit (mAb2b) showed similar expression
levels in all genotypes examined (Figures 2A and 2B).
Neither total GlyR a nor a1 levels were significantly
altered by the D80A substitution as revealed by normal-
izing densitometrically determined band intensities
to syntaxin expression (mAb4a immunoreactivity in
homozygous Glra1(D80A)—115% 6 10% of WT; n = 6;
p > 0.05; mAb2b immunoreactivity in homozygous
Glra1(D80A)—127%6 34% of WT; n = 5; p > 0.05). Since
the GlyR a1 subunit is the predominant subunit in adult
spinal cord and accounts for high-affinity [3H]strychnine
binding, we also performed binding assays on spinal
cord membrane preparations at ligand concentrations
ranging from 1 to 200 nM. [3H]strychnine bound to WT
and homozygous Glra1(D80A) membranes with similar
dissociation constants (KDs of 13.2 6 3.2 nM and 24.8 6
5.9 nM; n = 3; p > 0.05) and Bmax values (874 6 76 and
1112 6 165 fmol/mg protein, n = 3; p > 0.05;
Figure 2C). Thus, the D80A mutation does not signifi-
cantly affect receptor expression or ligand binding
properties in vivo. We also examined the synaptic local-
ization of the a1(D80A) subunit by performing immuno-
cytochemistry on spinal cord sections with the a1-
specific antibody mAb2b (Figure 2D). The punctate
distribution of mAb2b staining, indicative of postsynap-
tically clustered GlyRs, was indistinguishable between
WT and homozygous Glra1(D80A) sections, as revealed
by respective cluster counts (43 6 17 and 51 6 13
puncta per 100 mm2, respectively; n = 4 each; p > 0.05;
Figure 2E). We therefore conclude that the D80A muta-
tion has no significant effects on GlyR expression and
synaptic localization.
Homozygous Glra1(D80A) Mice Develop a Severe
Neuromotor Phenotype
During the second postnatal week, at around P12, homo-
zygous Glra1(D80A) mice developed a severe neuromo-
tor phenotype characterized by an increased muscular
tone and inducible tremor, which persisted throughout
adulthood. Nevertheless, the homozygous animals
were fertile, survived normally, and showed only a mar-
ginal reduction in body weight (<10%) as compared to
their WT and heterozygous littermates (data not shown).
To characterize the phenotypic properties of adult
homozygous Glra1(D80A) mutant mice more closely,
simple handling assays were performed. When picked
up by the tail, homozygous mutants displayed a charac-
teristic hind feet clasping behavior (Figure 3A). In
contrast, WT and heterozygous mice balanced their
position by spreading out the legs (Figure 3A). As a
second criterion to evaluate neuromotor performance,
littermates were screened for the development of
tremor after suspending them by their tails onto an
electromechanical transducer, as described previously
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(A) Gene targeting strategy. I: Schematic
representation of the Glra1 locus. Exons are
indicated by gray boxes and transmembrane
domains by black boxes within exons. II: The
D80A substitution was introduced into ES
cells by using a replacement type targeting
vector which carried the mutation together
with an adjacent silent diagnostic XbaI re-
striction site and a floxed (triangles) intronic
neomycin selection cassette. III: Targeted
locus after homologous recombination. The
neomycin cassette was removed by trans-
fecting ES cells carrying the mutant locus
with a Cre expression vector. IV: Resulting
ES cell clones were used for blastocyst injec-
tion. Arrows indicate primers used for PCR
screening. The 30-probe flanking the target-
ing vector is drawn as a solid bar. B: BclI; H:
HindIII; N: NotI; X: XbaI; Ba: BamHI.
(B) Homologous recombination in ES cell
clones. Insertion of the construct is revealed
by Southern blot analysis using a BclI/XbaI
digest of genomic DNA. The 30 probe hybrid-
izes to a 2.4 kb WT and a 3.2 kb mutant
fragment.
(C) Cre-mediated deletion of the neomycin
resistance cassette in ES cell clones is con-
firmed by Southern blot analysis of genomic
DNA using a BclI-XbaI digest: the 30 probe
hybridizes to a 2.4 kb WT and a 1.3 kb mutant
fragment, in contrast to the 3.2 kb mutant
fragment seen in the parental ES cells.
(D) Southern blot analysis of genomic DNA
using a XbaI digest shows that the 30 probe
hybridizes to a 3.5 kb WT, or a 1.3 kb mutant
fragment, or both, in WT and homozygous or
heterozygous mutant animals, respectively.(Becker et al., 2002). In contrast to WT littermates, homo-
zygous Glra1(D80A) mice developed inducible tremor,
as demonstrated by high amplitudes of the electrome-
chanical tracings which reflect tremor-induced move-
ments (Figure 3B). Also, the righting response of the
mutants was strongly impaired. WT animals immediately
turned themselves over to get back on their feet
(Figure 3C). In contrast, homozygous Glra1(D80A) mice
displayed a mean righting time of >10 s (Figure 3C). Fur-
thermore, footprint analysis disclosed clear differences
in motor performance. WT animals displayed alternating
positioning of hind- and forepaws, resulting in overlap-
ping footprints and a uniform gait width (Figure 3D).
In contrast, homozygous Glra1(D80A) mice produced
traces that never showed overlapping footprints (Fig-
ure 3D). Quantification of the gait analysis revealed that
homozygous Glra1(D80A) show a significantly shorter
stride (WT, 61 6 11 mm versus Glra1(D80A), 38 6
9 mm; n = 7; p < 0.05), as well as a narrower base of thehind limbs (WT, 35 6 7 mm versus Glra1(D80A), 27 6
6 mm; n = 7; p < 0.05).
Altered Sensory Processing in Homozygous
Glra1(D80A) Mice
To address whether adult homozygous Glra1(D80A)
mice also show alterations in sensory functions, we an-
alyzed parameters of visual and acoustic signal process-
ing. First, we recorded dark- (DA) and light-adapted (LA)
electroretinograms (ERGs) from homozygous Glra1
(D80A) and WT mice (n = 6, each). Figure 4A shows rep-
resentative DA and LA ERGs recorded from a WT and
a homozygous Glra1(D80A) mouse in response to full-
field flash stimuli at ten different stimulus intensities.
We found a moderate increase in scotopic (DA) b-wave
amplitude in homozygous Glra1(D80A) mice, which
was even more prominent under LA conditions when
cones are stimulated (Figures 4A and 4B, indicated by
filled arrows). However, no difference was seen in the
Neuron
682Figure 2. GlyR Expression in Glra1(D80A)
Mice
(A–D) Expression of WT andGlra1(D80A) sub-
units in spinal cord.
(A and B) Western blot analysis of spinal cord
fractions prepared from P21 WT, heterozy-
gous, and homozygous Glra1(D80A) litter-
mates, using antibodies recognizing (A) all
GlyR a subunits (mAb4a) or (B) only the
GlyR a1 subunit (mAb2b). Equal amounts of
protein were loaded and probed with the indi-
cated antisera. Bottom lanes: parallel detec-
tion of syntaxin was used as internal loading
control. Note that expression levels are simi-
lar between genotypes.
(C) [3H]Strychnine binding to spinal cord
membranes from WT (solid line) and homozy-
gous Glra1(D80A) (dotted line) mice.
(D) Transversal sections through the lumbar
spinal cord of P21 WT and homozygous Glra1
(D80A) littermates were processed for immu-
nohistochemistry with mAb2b. Note similar
punctate GlyR a1 staining. Scale bars, 5 mM.
(E) Quantification of a1 GlyR subunit puncta in
spinal cord sections of WT and homozygous
Glra1(D80A) littermates (n = 4, each).
Error bars indicate6 SEM.case of the a-wave (Figures 4A and 4B, indicated by
open arrows). Plotting the intensity response functions
for the b-wave peak amplitudes revealed significant dif-
ferences (Figure 4C; n = 6). Whereas in the DA condition
the median of the b-wave amplitude in homozygous
Glra1(D80A) mice was only slightly above the 95% quan-
tile of that of the WT controls (the upper limit of the nor-
mal range), the median of the b-wave amplitude in the LA
condition was significantly increased in homozygous
Glra1(D80A) mice (Figure 4C). Furthermore, the mice
carrying the D80A substitution had increased photopic
oscillatory potentials (OPs), seen as rhythmic oscilla-tions superimposed on the b-wave of the ERG (compare
OPs of WT and homozygous Glra1(D80A) mice in Fig-
ures 4A and 4B). Thus theGlra1(D80A) substitution alters
transmission of the visual signal by bipolar cells (b-wave)
and AII amacrine cells (OPs), consistent with an impaired
glycinergic suppression of cone signal transmission in
Glra1(D80A) mice.
An increased acoustic startle response (ASR) is a hall-
mark of mutations affecting GlyR genes and seen in both
mice and humans (Schofield, 2002). We also found an
enhanced response of homozygous Glra1(D80A) mice
to sudden loud acoustic stimuli (ASR), as detected byFigure 3. Motor Behavior of Homozygous
Glra1(D80A) Mice
(A) Hind feet clasping phenotype in adult
Glra1(D80A) mice.
(B) Electromechanical tracings of induced
tremor-derived movement recorded from
WT and Glra1(D80A) homozygous animals
positioned as in (A). The amplitudes are
proportional to the strength of movement
recorded over time. Note the appearance of
strong tremor in Glra1(D80A) mice.
(C) Righting time. The time required to right
after being turned to the back was signifi-
cantly prolonged in Glra1(D80A) mutants as
compared to WT animals (n = 8; p < 0.01).
(D) Representative footprints of WT and
Glra1(D80A) animals. Notice the ‘‘spastic’’
gait characterized by a decreased stride
width of the hindlimbs and nonoverlapping
forelimb and hindlimb strides.
Error bars indicate 6 SEM.
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gous Glra1(D80A) Mice
(A–C) Electrophysiological evaluation of reti-
nal function in 3-month-old homozygous
Glra1(D80A) mice.
(A) Individual traces of dark- and light-adap-
ted ERGs recorded from WT (black) and ho-
mozygousGlra1(D80A) (red) mice in response
to stimuli of increasing intensities. Note differ-
ences between WT and Glra1(D80A) mice in
photopic b-wave amplitude at higher flash
intensities (b-wave and a-wave are indicated
by filled and open arrows, respectively).
(B) Superposition of responses shown in (A).
By increasing stimulus luminance, the differ-
ence in b-wave but not a-wave amplitudes
becomes obvious (indicated by solid arrow).
(C) Qualitative comparison of homozygous
Glra1(D80A) and WT mice. b-Wave ampli-
tudes plotted as a function of the logarithm
of flash intensity. Data are from six homozy-
gous Glra1(D80A) and WT littermates each.
Crosses indicate the median, boxes the
25%–75% quantile range and bars the 5%
and 95% quantiles, respectively, of the
Glra1(D80A) data (red). The Glra1(D80A)
mice show significantly larger responses in
the cone-driven light-adapted ERG than WT
controls (5% and 95% quantiles of WT are
indicated in black). DA: dark-adapted; LA:
light-adapted.
(D) ASR incidence in WT and homozygous
Glra1(D80A) mice at three different stimulus
intensities (70–90 dB). Note significantly
increased ASRs to 70 and 80 dB stimuli in
homozygous Glra1(D80A) as compared to
WT mice (n = 7; p < 0.05).
Error bars indicate6 SEM.coordinated muscle contraction. When measuring ASRs
to three different stimulus intensities, mutant mice
showed already at relatively low intensity levels (70 dB)
a pronounced startle reaction, whereas WT mice were
largely insensitive to this stimulus intensity (Figure 4D).
Only at high intensities (R80 dB), ASR was also seen
in most WT animals. Together, the sensorimotor pheno-
type of Glra1(D80A) mice resembles those of previously
described GlyR mutants in mouse (spasmodic, spastic,
or oscillator) and man (hyperekplexia) as well as the
symptoms produced upon subconvulsive strychnine
poisoning (Schofield, 2002).
Analysis of Glycine-Mediated Currents
in Glra1(D80A) Spinal Neurons
To examine the functional consequences of the D80A
substitution, we recorded GlyR currents in cultured spi-
nal neurons prepared from E13 WT and homozygous
Glra1(D80A) mice after 21 days of in vitro differentiation,
i.e., a time period corresponding to the end of the
second postnatal week. The analysis of glycine dose-
response curves in these cultures revealed indistin-guishable glycine potencies in cells from WT (EC50 =
276 3.8 mM) and homozygous Glra1(D80A) mice (EC50 =
346 5.3 mM; n = 5; p > 0.05; Figure 5A). Analysis of Zn2+
dose-response curves revealed a significant reduction in
the potentiation of glycine currents by low concentra-
tions of Zn2+ in cells from homozygous Glra1(D80A)
mice as compared to WT neurons (53% 6 28% versus
117% 6 33% at 5 mM Zn2+, respectively; n = 7; p < 0.05;
Figure 5B). In contrast, Zn2+-mediated inhibition at
higher concentrations of the metal ion was not affected
(Figure 5B).
In recombinant a1 GlyRs, the D80A substitution abol-
ishes Zn2+ potentiation of glycine-mediated currents
(Lynch et al., 1998). The residual Zn2+ potentiation
seen in whole-cell currents recorded from homozygous
Glra1(D80A) neurons may therefore reflect the expres-
sion of GlyR a subunits other than a1, which also are
potentiated by low concentrations of Zn2+ (Laube
et al., 1995). Immunostainings of the cultured neurons
with an antibody specific for the perinatally expressed
a2 subunit of the GlyR revealed that virtually all cells
exhibiting a1 GlyR staining by mAb2b also showed a2
Neuron
684Figure 5. Electrophysiological Characteriza-
tion of GlyR-Mediated Whole-Cell Currents
Recorded from Cultured WT and Homozy-
gous Glra1(D80A) Spinal Neurons after 21
Days In Vitro (DIV)
(A and B) Whole-cell patch-clamp analysis of
glycine responses.
(A) Left: Responses of single cells to increas-
ing concentrations of 10, 20, 50, 100, 200, and
500 mM glycine. Right: Pooled glycine dose-
response curves for WT and homozygous
Glra1(D80A) cells.
(B) Effect of Zn2+ on agonist-induced GlyR
currents. Left: Traces represent potentiation
and inhibition of responses to 20 mM glycine
of WT and Glra1(D80A) neurons by 5 and
100 mM Zn2+, respectively. Right: Average
potentiation by 5 mM Zn2+ in WT and
Glra1(D80A) cells (n = 5; p < 0.05).
(C) Immunostaining of individual neurons
with GlyR a1 (green) and a2 (red) specific
antibodies.
(D) Same, but immunostaining for the GlyR a2
subunit (red) and gephyrin (green). Colocali-
zation is indicated in yellow. Scale bars,
10 mm.
(E) Quantification of GlyR a2 subunit colocal-
ization in DIV21 cultured spinal neurons with
the a1 subunit and gephyrin, respectively
(n = 5, each).
Error bars indicate 6 SEM.GlyR immunoreactivity in double-staining experiments
(Figure 5C). As demonstrated in Figure 5C, the a2 immu-
noreactivity was distributed over the entire cell and
appeared to be less punctate as compared to the focal
pattern found with antibodies against the a1 subunit or
the postsynaptic GlyR clustering protein gephyrin (Fig-
ure 5D). Quantification of the immunoreactive structures
revealed that only 28% 6 14% and 17% 6 13% (n = 5)
of the a2 puncta colocalized with a1 and gephyrin,
respectively (Figure 5E). Thus, most a2 GlyRs are not
synaptically localized but represent extrasynaptic re-
ceptors. Consequently, the residual Zn2+ potentiation
seen in homozygousGlra1(D80A) neurons mainly results
from the modulation of nonsynaptic GlyRs.
Loss of Zn2+-Mediated Potentiation of Glycinergic
mIPSCs in HomozygousGlra1(D80A) Spinal Neurons
To investigate the effect of the D80A substitution on
GlyR-mediated synaptic currents, we first analyzed the
pharmacological properties of recombinant hetero-
oligomeric a1b GlyRs, which are thought to be synapti-
cally localized (Laube et al., 2002). Electrophysiological
analysis of glycine dose responses revealed indistin-
guishable glycine EC50 values at WT a1b (EC50 = 74 6
18 mM) and a1(D80A)b (EC50 = 68 6 13 mM; n = 4, each;
p > 0.05) coexpressing human embryonic kidney
(HEK)293 cells (Figure 6A). To reveal how the mutation
affects Zn2+ modulation of hetero-oligomeric a1bGlyRs,
Zn2+ dose-response curves were analyzed in the
presence of submaximal (50 mM) and saturating (500
mM) glycine concentrations. Figure 6B shows that po-
tentiation of glycine currents by low concentrations ofZn2+ was lost in HEK cells expressing a1(D80A)b hetero-
oligomers. Thus, the a1(D80A) substitution suppresses
Zn2+ potentiation in both homo- and hetero-oligomeric
GlyRs. In contrast, at saturating glycine concentrations,
where Zn2+ exerts only an inhibitory effect on glycine
currents (Laube et al., 1995), no difference in the IC50
values of Zn2+ was found between WT a1b- and
a1(D80A)b-expressing HEK cells (208 6 41 mM and
167 6 34 mM, respectively; n = 5; p > 0.05). This con-
firmed that the a1(D80A) mutant selectively suppresses
Zn2+-mediated potentiation rather than inhibition of the
heteromeric receptor. To exclude that the bath solution
might be contaminated by low concentrations of Zn2+,
we added the chelator tricine (10 mM). This had no sig-
nificant effect on both glycine currents (Figure 6B) and
Zn2+ dose-response curves when recorded in defined
Zn2+ buffers (data not shown; see Paoletti et al.
[1997]). Similar results were obtained with 1 mM Ca2+-
EDTA, another effective Zn2+ chelator (data not shown).
Thus, Zn2+ contamination was not relevant under our
recording conditions.
We next examined the effect of the D80A substitution
on synaptic currents by analyzing glycinergic mIPSCs in
spinal cord cultures prepared from E13 WT and homozy-
gous Glra1(D80A) mice after 21 days of in vitro differen-
tiation (Figure 6C). Neurons from WT and homozygous
Glra1(D80A) animals showed mIPSCs with variable, but
similar frequencies (WT, 9.465.2 Hz versusGlra1(D80A),
5.2 6 4.2 Hz; n = 6; p > 0.05) and mean amplitudes (WT,
44 6 14.7 pA versus Glra1(D80A), 49 6 21.4 pA; n = 6;
p > 0.05). Application of 500 nM strychnine abolished
mIPSCs in both WT and homozygous Glra1(D80A)
Zn2+ Modulation of the Glycine Receptor
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GlyRs
(A and B) Whole-cell patch-clamp analysis of glycine responses
elicited in HEK cells expressing a1b and a1D80Ab hetero-oligomeric
GlyRs.
(A) Glycine dose-response curves for a1b and a1D80Ab cells.
(B) Current traces elicited by 50 mM glycine in the absence and pres-
ence of 5 mM Zn2+ (left) and respective Zn2+ dose-response curves
(right) (n = 5, each). Note that addition of tricine (10 mM) had no effect
on the glycine current.
(C–E) Glycinergic mIPSCs recorded from cultured spinal neurons of
WT and homozygous Glra1(D80A) mice at DIV21.
(C) Consecutive traces showing mIPSCs prior to (upper trace) and
during (middle trace) the application of 5 mM Zn2+ and in the pres-
ence (lower trace) of 500 nM strychnine (+Stry).
(D) Superimposed averaged glycinergic mIPSCs (n = 50) recorded
from WT and homozygous Glra1(D80A) neurons. Note similar decay
kinetics in both genotypes.
(E) Cumulative probability plot of mIPSCs amplitudes recorded prior
to and during the application of 5 mM Zn2+ (+Zn2+) from WT (solid
lines) and homozygous Glra1(D80A) (dotted lines) neurons.
(F) Summary graph showing the relative changes in mIPSC mean
amplitudes and frequencies found in WT and homozygouscultures, thereby confirming the glycinergic nature of
the events recorded (Figure 6C). In addition, upon super-
position of 50 mIPSC events, no differences were found
in mIPSC decay kinetics between WT (t = 11.26 1.8 ms)
and homozygous Glra1(D80A) (t = 13.4 6 2.1 ms; n =
5 each; p > 0.05) neurons, indicating that the D80A sub-
stitution does not alter the kinetic properties of basic
glycinergic transmission (Figure 6D). We then added
5mM Zn2+, a concentration known to increase glycinergic
mIPSC amplitude and frequency (Suwa et al., 2001;
Laube, 2002) without potentiating currents of a1(D80A)b
hetero-oligomers (Figure 6B). Notably, in the presence
of this low Zn2+ concentration mIPSC amplitudes were
significantly inhibited in homozygous Glra1(D80A) neu-
rons (219% 6 6%; n = 6; p < 0.05; paired Student’s
t test), whereas in WT cells a mean increase of 41% 6
9% (n = 6; p < 0.01; paired Student’s t test) was observed
(Figure 6F). For example, the mean peak amplitudes of
the representative mIPSCs shown in Figure 6C were
38 6 14.3 pA (WT) and 41 6 16.6 pA (Glra1(D80A)) in
the absence of Zn2+. After addition of 5 mM Zn2+, the
mean amplitudes of the mIPSCs shown in Figure 6C in-
creased to 57 6 23.4 pA for WT cells but decreased to
31 6 12.1 pA in Glra1(D80A) neurons. In WT cultures,
a decrease in mIPSC amplitude was only seen at higher
Zn2+ concentrations (>20 mM) (see Laube [2002]). Cumu-
lative probability histograms of the mIPSC amplitudes
confirmed the observed reduction of the mean amplitude
in homozygous Glra1(D80A) cells by a respective Zn2+-
induced shift toward the left, whereas WT cultures
displayed an opposite effect upon Zn2+ addition
(Figure 6E). In contrast, mIPSC frequencies were not dif-
ferentially affected (Figure 6F). To confirm that under our
culture conditions the a1 subunit was properly ex-
pressed and targeted to postsynaptic sites, the localiza-
tion of GlyR a1(D80A) was examined by immunocyto-
chemistry after 3 weeks in vitro. In both WT (data not
shown) and homozygous Glra1(D80A) cells (Figure 6G),
a typical membraneous punctate staining was produced
by the a1 specific mAb2b antibody, as revealed upon
confocal sectioning. Since these GlyR punctae are
known to represent synaptically localized a1 containing
GlyRs, this confirms proper expression and synaptic
targeting of the mutant subunit in our cultures. These
results are consistent with the D80A mutation affecting
glycinergic inhibition by selectively eliminating Zn2+
potentiation of synaptically localized a1b GlyRs.
Altered Zn2+-Dependence of Glycinergic IPSCs
in Homozygous Glra1(D80A) Hypoglossal
Motoneurons
To examine the effects of Zn2+ on glycinergic neuro-
transmission in situ, spontaneous IPSCs were recorded
in hypoglossal motoneurons of acute brainstem slices
Glra1(D80A) neurons. Mean changes are expressed as percentages
of control values obtained for mIPSCs recorded in the absence of
Zn2+ for both WT (black bars) and homozygous Glra1(D80A) (white
bars) neurons (n = 6; p < 0.01).
(G) Immunohistochemical localization of a1 subunit containing GlyR
clusters in homozygous Glra1(D80A) spinal neurons at DIV21. Scale
bar, 10 mm.
Error bars indicate 6 SEM.
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686from P8 WT and homozygous Glra1(D80A) mice. At this
age, a1 subunit containing GlyRs represent already
>60% of the total GlyR protein in rodent spinal cord
(Becker et al., 1992). Hypoglossal motoneurons from
WT animals generated glycinergic IPSCs with a mean
amplitude of 67.0 6 27.0 pA and a decay time of t =
13.56 3.8 ms (n = 6; Figures 7A and 7B). In homozygous
Glra1(D80A) neurons, mean IPSC amplitudes and decay
kinetics were similar (67.3 6 21.5 pA and t = 12.3 6 4.2
ms, respectively; n = 8; p > 0.05; Figures 7A and 7B). In
addition, mean IPSC frequencies in WT and homozy-
gous Glra1(D80A) cells were not statistically different
(WT, 11.1 6 5.1 Hz versus Glra1(D80A), 13.9 6 3.4 Hz;
n = 6; p > 0.05). Upon addition of 5 mM Zn2+, a concentra-
tion which efficiently potentiates both recombinant a1b
GlyRs and mIPSCs in dissociated spinal cultures, IPSCs
were not potentiated, consistent with endogenous free
Zn2+ being present in slice preparations at concentra-
tions sufficient to preclude potentiation by the exoge-
nously applied metal ion (Lu et al., 2000; Suwa et al.,
2001). We therefore complexed endogenous Zn2+ by tri-
cine (10 mM). This reduced the mean amplitude of IPSCs
in WT slices by 44.1% 6 18.5% (from 67.0 6 27.0 pA to
38.4 6 24.2 pA; n = 6; p < 0.01; paired Student’s t test;
Figures 7A and 7C), while no significant effect on IPSC
frequency was seen (11.1 6 5.1 Hz versus 9.5 6 5.2
Hz; n = 6; p > 0.05). Readjustment to a calculated free
Zn2+ concentration of ca. 5 mM by adding 500 mM Zn2+
to the tricine buffer (Paoletti et al., 1997) resulted in a sig-
nificant rescue of glycinergic IPSC mean amplitude
(Figure 7A, increase by 35.4% 6 12.9%; n = 8; p <
0.05; paired Student’s t test). This indicates that endog-
enous Zn2+ indeed contributes to the regulation of glyci-
nergic IPSC amplitudes in our WT slice preparations. In
contrast, slices made from homozygous Glra1(D80A)
mice showed no significant effect of tricine on IPSC am-
plitude, with the mean amplitude being reduced by only
14.0% 6 8.6% (from 67.3 6 21.5 pA to 57.7 6 17.5 pA;
n = 8; p > 0.05; paired Student’s t test); again, no effect
on IPSC frequencies was detected (13.96 3.4 Hz versus
11.2 6 3.8 Hz; n = 8; p > 0.05). Although mean IPSC
amplitudes did not differ significantly between WT and
homozygous Glra1(D80A) cells after the tricine treat-
ment (38.4 6 24.2 pA versus 57.7 6 17.5 pA; n = 8; p =
0.054), the differential effects of tricine on IPSC mean
amplitudes in WT and Glra1(D80A) preparations were
highly significant (decrease in WT, 44.1% 6 18.4% ver-
sus Glra1, 12.8% 6 7.3%; n = 8; p < 0.001; Figure 7C).
Moreover, the coefficient of variation calculated for the
mean amplitude values was reduced upon tricine addi-
tion in the case of WT but not homozygous Glra1(D80A)
slices (from 1.06 0.37 to 0.76 0.2 for WT; n = 8; p < 0.05,
paired Student’s t test, and from 0.78 6 0.20 to 0.78 6
0.27 for Glra1(D80A), respectively; p > 0.05, paired
Student’s t test). Thus, endogenous Zn2+ accounts for
the higher variability of glycinergic IPSC amplitudes
seen in WT as compared to homozygous Glra1(D80A)
neurons.
To investigate whether tonic glycinergic inhibition
mediated by extrasynaptic GlyRs may also be affected
by Zn2+ chelation, we analyzed the holding currents
(Ihold) of WT and Glra1(D80A) neurons before and after
adding 10 mM tricine. Mean holding currents in WT
and homozygous Glra1(D80A) cells were neither before(WT, 2363 6 191 pA versus. Glra1(D80A), 2394 6
139 pA) nor after the addition of tricine statistically differ-
ent (WT, 2425 6 199 pA versus Glra1(D80A), 2594 6
157 pA; n = 8; p > 0.05, ANOVA). Apparently, ambient
glycine concentrations do not contribute to tonic inhibi-
tion of hypoglossal motoneurons. Consistent with this
interpretation, 1 mM strychnine did not alter Ihold values
in both WT and Glra1(D80A) cells (WT, 2201 6 115 pA
versus Glra1(D80A), 2216 6 117 pA; n = 8; p > 0.05,
paired Student’s t test). We conclude that tricine affects
IPSCs primarily due to a loss of synaptic rather than
extrasynaptic GlyR potentiation.
We also recorded sIPSCs from hypoglossal moto-
neurons of WT and homozygous Glra1(D80A) mice at
P14–P16, i.e., at a stage at which the phenotype of the
Glra1(D80A) mouse is fully manifest. Hypoglossal moto-
neurons from WT animals generated glycinergic IPSCs
with a mean amplitude of 99.4 6 8.0 pA and a decay
time of t = 6.97 6 0.26 ms (n = 17, Figures 7D and 7E).
In homozygous Glra1(D80A) neurons, mean IPSC
amplitudes and decay times were significantly reduced
(58.3 6 7.7 pA and 2.99 6 0.27 ms, respectively; n = 7;
p < 0.01; Figure 7F). Thus, differences in IPSC character-
istics apparently become detectable when the transition
from a2- to a1-containing receptors is complete (Becker
et al., 1992). Together, these data show that glycinergic
IPSCs are altered in hypoglossal motoneurons of
Glra1(D80A) mice due to a loss of Zn2+ potentiation.
Discussion
In this study, we report the first in vivo evidence for Zn2+
modulation of a ligand-gated ion channel in the mamma-
lian CNS. By introducing a point mutation into the murine
Glra1 gene, we generated mice which display a severe
hyperekplexia phenotype characterized by the develop-
ment of inducible tremor, a delayed righting reflex, an
abnormal gait, an increase in the b-wave amplitude of
the ERG, and an enhanced ASR. These symptoms are
hallmarks of impaired glycinergic neurotransmission
(Schofield, 2002). As demonstrated by electrophysiolog-
ical recordings in spinal cultures and brainstem slices,
the Glra1(D80A) mutation caused a significant reduction
in the Zn2+-mediated potentiation of glycinergic IPSC
amplitudes without altering basic GlyR function. Our
results establish an essential role for Zn2+ in CNS in-
hibition and indicate that Zn2+ binding to synaptic GlyRs
is crucial for proper sensorimotor coordination and
function.
In murine spinal cord, the subunit composition of
GlyRs changes during postnatal development (Becker
et al., 1988). During the first and second postnatal
week, the neonatal a2 subunit is replaced by adult a1
subunit containing receptors. At P8, R60% of the total
GlyRs in WT spinal cord contain a1, and at P14 >90%
(Becker et al., 1992). This GlyR isoform switch is the
cause for the late onset of neuromotor symptoms at
the end of the second postnatal week in the mutant
mice spasmodic and oscillator which carry mutations
in Glra1 (Schofield, 2002). The appearance of the senso-
rimotor phenotype in Glra1(D80A) mice at around P12
thus coincides with the loss of GlyR a2 isoform expres-
sion and the onset of hyperekplexia symptoms in the
natural Glra1 mouse mutants. This suggests that the
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687Figure 7. Spontaneous IPSCs Recorded
from Hypoglossal Motoneurons In Situ
(A)–(C) P8; (D)–(F) P14.
(A) Typical spontaneous synaptic activity of
hypoglossal motoneurons from P8 WT and
homozygous Glra1(D80A) mice under control
conditions, after application of tricine (10
mM) and after readjustment to a calculated
free Zn2+ concentration of ca. 5 mM by adding
500 mM Zn2+ to the tricine buffer. Note the
recovery of IPSC amplitude after readding
Zn2+ to the WT slice.
(B) Mean amplitudes (black bars) and decay
constants (gray bars) of spontaneous IPSCs
recorded from P8 WT and homozygous Glra1
(D80A) slices.
(C) Relative changes in mean amplitude of
IPSCs caused by the addition of 10 mM
tricine to slices from P8 WT and homozygous
Glra1(D80A) mice.
(D) Typical spontaneous synaptic activity in
hypoglossal motoneurons from P14 WT and
homozygous Glra1(D80A) mice recorded
under control conditions.
(E) Superimposed averaged glycinergic
IPSCs (n = 50) recorded from P14 WT and in
homozygous Glra1(D80A) neurons. Note
different decay kinetics in both genotypes.
(F) Mean amplitudes (black bars) and decay
constants (gray bars) of spontaneous IPSCs
recorded from P14 WT and homozygous
Glra1(D80A) slices.
Error bars indicate 6 SEM.developmental pattern of a1 subunit expression is
unchanged in homozygous Glra1(D80A) mice.
Different lines of evidence indicate that the phenotype
of homozygous Glra1(D80A) mice can be confidently
attributed to a selective loss of synaptic Zn2+ potentia-
tion. First, in heterologous expression experiments
substitution of aspartate 80 by either glycine or alanine
has been shown to selectively suppress Zn2+ potentia-
tion of a1 GlyRs without altering the glycine dose-
response relationship, open probability and single-
channel conductance (Lynch et al., 1998; Laube et al.,
2000). Similarly, here no changes in basic GlyR physiol-
ogy could be detected with recombinant a1D80Ab GlyRs
and homozygous Glra1(D80A) neurons. Second, GlyR
expression and synaptic localization as monitored by
Western analysis, [3H]strychnine binding, and immuno-
cytochemistry were not significantly altered in the
homozygous mutant mice. Third, glycinergic IPSC am-
plitudes, decay kinetics, and frequencies were similar
in cultured spinal neurons and P8 brainstemhypoglossal
motoneurons prepared from WT and homozygous
Glra1(D80A) animals. Only when recording glycinergic
IPSCs from hypoglossal motoneurons at P14, i.e.,
a time point where the a2 to a1 subunit switch is com-
plete and the hyperekplexia phenotype manifest, signif-
icantly reduced amplitudes and shorter decay times
were found in Glra1(D80A) cells. This is consistent with
ambient Zn2+ increasing the IPSC amplitudes and decaytime of WT a1 but not Glra1(D80A) GlyRs (Suwa et al.,
2001; Laube, 2002). Concurrently, chelation of Zn2+ by
tricine disclosed comparable differences in glycinergic
IPSCs between P8 WT and Glra1(D80A) hypoglossal
neurons, confirming that the majority of GlyRs present
at this stage contains the a1 subunit. Notably, the Ihold
of the hypoglossal neurons was neither affected by
strychnine nor tricine, indicating that the hyperekplexia
phenotype of homozygous Glra1(D80A) mice is not
due to altered tonic inhibition mediated by extracellular
GlyRs. In contrast to our findings with homozygous
Glra1(D80A) mice, the decrease in glycinergic IPSC am-
plitudes observed in spasmodic animals is caused by
a reduced glycine affinity resulting from the A52S muta-
tion in Glra1 (Graham et al., 2006). In conclusion, the
phenotype of Glra1(D80A) mice is due to impaired Zn2+
potentiation rather than a reduction or malfunctioning
of the synaptically localized mutant GlyRs.
Earlier reports showing that histochemically detect-
able Zn2+ is highly enriched within glutamatergic mossy
fiber terminals of the hippocampus had led to the
proposal that synaptic Zn2+ modulates primarily excit-
atory neurotransmission (Li et al., 2003). Indeed, low
micromolar concentrations of exogenous Zn2+ potently
inhibit NMDA receptor currents (Paoletti et al., 1997).
More recent studies revealed an enrichment of Zn2+
also in inhibitory nerve terminals (Vela´zquez et al.,
1999; Danscher et al., 2001; Wang et al., 2001, 2002;
Neuron
688Danscher and Stoltenberg, 2005). At central synapses,
the Zn2+ transporter ZnT3 is thought to accumulate
Zn2+ within synaptic vesicles (Cole et al., 1999). The
question therefore arises why homozygous Glra1(D80A)
mice develop hyperekplexia, whereas no behavioral
impairments have been found in ZnT3-deficient mice
(Cole et al., 1999). One possible explanation could be
that Zn2+ transporters other than ZnT3 mediate synaptic
vesicle loading at inhibitory synapses where the conse-
quences of ZnT3 deficiency have not been studied.
Alternatively, nonvesicular mechanisms may allow for
Zn2+ loading of and release from synaptic structures.
ZnT3 independent accumulation of Zn2+ has been dem-
onstrated in hippocampal neurons (Lee et al., 2000) and
in synaptic regions of the developing barrel cortex
(Liguz-Lecznar et al., 2005). Apparently, the large reper-
toire of 10 Slc30s (ZnT) and 14 Slc39s (Zip) genes allows
to functionally compensate for ZnT3 deficiency which
likely accounts for the lack of hyperekplexia symptoms
in the ZnT3 knockout mice.
The basal concentrations of free Zn2+ at inhibitory
synapses are unknown. However, in our brainstem
slices, tricine reduced IPSC amplitudes and the corre-
sponding coefficient of variation, whereas application
of 5 mM Zn2+ had no effect. This again indicates that at
least low micromolar concentrations of endogenous
Zn2+ must have been present in our preparation. Zn2+
has been shown to not only increase the amplitude of
GlyR responses at nonsaturating agonist concentra-
tions (Laube et al., 2000) but to also inhibit glycine
uptake mediated by the glial glycine transporter GlyT1
(Laube, 2002). Hence, Zn2+ might act synergistically by
both potentiating postsynaptic GlyR currents and re-
ducing glycine reuptake from the synaptic cleft, thereby
producing a higher occupancy of the synaptic recep-
tors. In conclusion, our in vivo data support the view
that nonsaturating amounts of glycine are released
during physiological inhibitory transmission.
Recent data indicate an enrichment of Zn2+ also in ter-
minals of dorsal spinal and retinal neurons (Vela´zquez
et al., 1999; Danscher et al., 2001; Ugarte and Osborne,
2001), suggesting that Zn2+ participates in the process-
ing of sensory signals. Here, we found that Glra1(D80A)
mice display profound changes in ERG and ASR. Our
ERG recordings from Glra1(D80A) mice indicate an
impaired glycinergic suppression of cone-mediated
transmission. Endogenous Zn2+ levels are high in the
vertebrate retina, and Zn2+ has been shown to modulate
light responses of color-opponent bipolar and amacrine
cells (Luo et al., 2002). Since the GlyR a1 subunit has
been shown to localize at synapses between AII ama-
crine and bipolar cells (Haverkamp et al., 2004), we
conclude from these morphological and functional
data that the loss of Zn2+ potentiation at the a1(D80A)
subunit reduces inhibition in the retina. This is consis-
tent with the enhancement of the b-wave amplitude
and the oscillatory potentials found in our experiments.
Likewise, the enhanced ASR seen in the Glra1(D80A)
mice suggests disinhibition of sensory input processing.
In conclusion, our data reveal an essential role of endog-
enous Zn2+ in shaping sensory transmission within
visual and auditory circuits.
The data presented in our paper disclose a pivotal role
of ambient synaptic Zn2+ for glycinergic neurotrans-mission in the context of normal animal behavior.
Whether activity-dependent alterations in extracellular
Zn2+ concentration contribute to different forms of plas-
ticity seen at inhibitory synapses, will have to be clarified
in future studies. Our results imply that manipulation of
synaptic Zn2+ levels by systemic Zn2+ intake or Zn2+-
specific chelators should affect glycinergic inhibition.
Our work thus highlights the complexity of potential
therapeutic interventions based on Zn2+-selective
chelation and/or Zn2+ supply (Doraiswamy and Fine-
frock, 2004), which may both perturb Zn2+ homeostasis
and result in an imbalance of excitatory and inhibitory
circuits.
Experimental Procedures
Generation of Glra1(D80A) ES Cells
A genomic fragment encompassing Glra1 exons 4 to 6 was isolated
from a P1 phage library. A 1 kb BglII-HindIII fragment containing
exon 4 was subcloned, and the substitution D80A and an additional
silent diagnostic XbaI restriction site were introduced by site-
directed mutagenesis. The mutant BglII-HindIII fragment was then
used to generate a D80A 6.1 kb HindIII fragment which formed the
long arm of homology. This fragment was blunt-end inserted into
HindIII/XbaI-digested pEasyflox, 50 of the loxP site flanking the neo-
mycin resistance cassette, thereby disrupting the XbaI site of the
vector (Figure 1A). A 735 bp HindIII/XbaI short arm of homology
was blunt end inserted into the BamHI site flanking the 30-loxP site
of the vector, disrupting the XbaI site of the genomic fragment. After
linearization with NotI at the 30-end of the short arm, the targeting
construct was transfected into E14 ES cells. Colonies resistant to
G-418 (Life Technologies) and 1-(20-deoxy-20-fluoro-b-D-arabinofur-
anosyl)-5-iodouracil (FIAU) were selected and screened for homolo-
gous integration of the construct by PCR using primers P1 (TGCTG
GGGGAAACTTCCTGACTAGG) and P2 (TGCTGAGTGTCCTTGGGA
CCATCAC) (Figure 1A). Homologous recombination events were
confirmed by Southern blot analysis. Removal of the loxP-flanked
neomycin cassette was achieved by transfection with the Cre
recombinase expression plasmid pgkCrebpA and verified by PCR
using primers P3 (GCCTACAATGAATACCCTGCCGATAG) and P4
(GGACACTCTGAAAGCTGATCCATAACTTC), as well as by Southern
blot analysis.
Generation of Glra1(D80A) Mice
Glra1(D80A) homozygous mutant mice were produced by injecting
ES cells with one engineeredGlra1(D80A) allele into C57BL/6 blasto-
cysts, which resulted in germline-transmitting chimeras. With
C57BL/6 females, these animals sired offspring heterozygous for
the mutation. For the analysis of sensorimotor behavior, chimeras
were backcrossed over five generations to C57BL/6 females, and
heterozygous offspring were then interbred to yield all genotypes.
Southern Blot Analysis
Genomic DNA of ES cells or mouse tissue was digested with XbaI, or
BclI and XbaI, separated by agarose gel electrophoresis, and trans-
ferred to Hybond N+ membrane (Amersham). 32P-labeled internal
probes were generated by random primer labeling (Prime It II, Stra-
tagene) of a 735 bp HindIII/XbaI fragment and hybridized to the
membrane.
Miscellaneous Methods
Western blot analysis of crude membrane fractions prepared from
mouse spinal cord with antibodies specific for GlyR a subunits
(mAb4a, 1:1000), the GlyR a1 subunit (mAb2b, 1:100), and syntaxin
(1:5000) and glycine-displaceable binding of [3H]strychnine (Du-
Pont NEN) were performed as described previously (Becker et al.,
1988). Western blots were scanned, and digitalized images were
analyzed for quantification using the software NIH-Image 1.63.
Behavioral Characterization of Glra1(D80A) Mice
The methods used for monitoring the neuromotor performance of
Glra1(D80A) mice (hind feet clasping, tremor recordings, righting
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et al., 2002). Footprint tracings were generated using P20–P30
mice from four different breeding pairs. Mouse footpads were
painted with Tempera paint, and mice were placed onto a sheet of
paper in a 50 cm long tube. The ASR was measured as described
(Plappert and Pilz, 2001). The protocol was designed to determine
strain sensitivity to startle stimuli of three intensities between 70
and 90 dBs presented randomly in 50 ms pulses, with an interval
of 30 s. In this protocol each mouse experienced 10 trials at each
noise level. ERGs were obtained as previously described (Seeliger
et al., 2001). At the age of 3 months, mice were dark adapted over-
night and anesthetized with ketamine (66.7 mg/kg) and xylazine
(11.7 mg/kg). The pupils were dilated, and single-flash ERG record-
ings were obtained under scotopic (DA) and photopic (LA) condi-
tions. Stimuli were presented with increasing intesities, reaching
from 1024 cd * s/M2 to 25 cd * s/m2, divided into ten steps. Ten
responses were averaged with an interstimulus interval (ISI) of 5 s
(for 0.1, 1, 10, 30, 100, 300 mcd*s/m2), 10 s (for 1 and 3 cd*s/m2),
or 20 s (for 10 and 25 cd*s/m2). In all tests conducted, WT littermates
served as controls for the respective homozygous mutant animals.
All procedures were approved by the animal care committee and
were in accordance with the German law on animal experimentation.
Spinal Cord Cultures and Immunochemistry
Spinal cord cultures were prepared from E13 mice and kept in
culture for 3 weeks as described (Laube, 2002). Immunolabeling of
spinal cord sections was performed as detailed previously (Kneus-
sel et al., 1999), using primary antibodies to the postsynaptic GlyR
clustering protein gephyrin (1:100) and the GlyR subunits a1 and
a2 (1:100). MAb2b is specific for the GlyR a1 subunit; mAb4a recog-
nizes all GlyR a subunits. A polyclonal goat antibody against the
N-terminal 18 residues of the GlyR a2 subunit was purchased from
Santa Cruz Biotechnology. Confocal microscopy was performed
using a confocal laser-scanning microscope Leica TCS-SP equip-
ped with the image software Leica-TCS-NT version 1.6.551. To
obtain spinal cord sections, tissue was cut in blocks of 5 mm and
immediately frozen. Cryostat sections (12 mM) were fixed for 2 min
in 4% (w/v) paraformaldehyde and processed for immunofluores-
cence. Punctate immunofluorescence was analyzed from confocal
images taken with a 633 objective. The number of puncta per
100 mm2 was counted from three different sections. Between 400
and 600 individual puncta were analyzed for the a1 GlyR subunit in
WT and Glra1(D80A) samples.
Electrophysiological Recording of Agonist-Evoked andmIPSCs
Whole-cell currents of transfected HEK293 (ATCC CRL 1573) were
analyzed as described previously (Laube et al., 2000). Cultured cells
were continuously superfused (0.5 ml per min) at room temperature
with an extracellular bathing solution containing 137 mM NaCl,
5.4 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 20 mM glucose, and
10 mM HEPES; adjusted to pH 7.2 with NaOH. Patch pipettes con-
tained 120 mM CsCl, 20 mM tetraethylammonium chloride, 1 mM
CaCl2, 2 mM MgCl2, 1 mM ATP, 11 mM EGTA, and 10 mM HEPES
(pH 7.2). Agonist-induced currents and mIPSCs in cultured spinal
neurons were recorded from neuronal somata in the whole-cell con-
figuration of the patch-clamp technique (Laube, 2002).
Electrophysiological Recordings from Acutely Isolated
Hypoglossal Slices
Three hundred micrometer slices (Vibroslicer, Leica VT 1000S, Leica
Instruments) of the caudal medulla containing the hypoglossal
nucleus from P8 or P14–P16 mice were prepared as described pre-
viously (Gomeza et al., 2003). Slices were stored for 1 hr at 37C in
a modified ACSF containing 118 mM NaCl, 3 mM KCl, 1 mM CaCl2,
5 mM MgCl2, 1 mM NaH2PO4, 25 mM NaHCO3, and 10 mM D-glucose
(pH 7.4). After a 1 hr preincubation, the slices were stored in ACSF
until transfer to a recording chamber. Hypoglossal motoneurons
were identified visually by their location, size, and shape. Whole-
cell recordings were obtained at 21C–24C with a L/M-PCA patch
clamp amplifier (E.S.F.). Patch electrodes were pulled from borosil-
icate glass capillaries (Biomedical Instruments) on a programmable
pipette-puller (Zeitz Instruments) and had resistances ranging from
2 to 4 MU when filled with intracellular solution containing 110 mM
CsCl, 30 mM TEA-Cl, 1 mM CaCl2, 2 mM MgCl2, 4 mM Na2ATP,10 mM HEPES, 10 mM EGTA (pH adjusted to 7.2 with KOH). 5-Lido-
caine-N-ethyl bromide (QX-314, 5 mM) was added to the electrode
solution to intracellularly block fast sodium currents. Currents
were filtered at 3 kHz with a four-pole Bessel filter and digitized at
10 kHz using a PowerLab inteface and Chart 4.2 software (ADInstru-
ments Pty. Ltd.). Spontaneous IPSC recordings were isolated
by adding 20 mM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX),
100 mM DL-2-amino-5-phosphonopentanoate (AP5), and 20 mM bi-
cuculline and analyzed using the MiniAnalysis program (Jaejin
Software) as described (Gomeza et al., 2003). To test the effect of
extracellular Zn2+ (used as ZnCl2) on GlyRs in situ, tricine (10 mM)
was added. For calculation of the time constants of IPSC decays,
only IPSCs that were larger then the averaged amplitude of the re-
corded IPSC and clearly separated form each other were used.
Spontaneous IPSC decay phases were fit by two exponentials,
and the mean time constant, tdecay, was calculated from the respec-
tive time constants and their relative amplitudes (a1,a2)—tdecay =
t1a1 + t2a2 using MiniAnalysis Program.
Statistical Analysis
Results represent means 6 SEM. Differences were tested by Stu-
dent’s two-tailed t test using GraphPad Prism version 4.0 (GraphPad
Software Inc.), if not indicated otherwise, and considered to be
statistically significant at p < 0.05 (*), p < 0.01 (**), and p < 0.001
(***). Homozygous Glra1(D80A) mice were compared to WT litter-
mates and age-matched C57B6 control mice.
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